The STEP 1 trial used 2.4 mg as the target maintenance dose and achieved average weight loss of 14.9% of body weight over 68 weeks
The question that ultimately matters is whether this convergence produces measurably better outcomes in real women
At the end of the day, we will need to tell those diabetic patients that they cant access the drug, and those patients get disappointed and stressed. Esther Walden, deputy head of care at Diabetes UK, welcomed the DHSCs guidance and called for clinicians to prioritise Ozempic for diabetics
These drugs work by mimicking the action of endogenous GLP-1 but at supraphysiological doses, resulting in stronger and longer-lasting effects on appetite suppression
After 28 days, potency cannot be guaranteed regardless of how the solution looks
By activating both of these hormone receptors simultaneously, Tirzepatide delivers a dual-action approach to weight management that sets it apart from older single-receptor medications